QurCan Therapeutics (formerly Nanology Labs Inc) is a biotechnology company using advanced nanoparticle drug-delivery technology to unleash the immense potential of next-generation biological and genetic medicine and deliver life-changing therapeutics.
QurCan's next generation nanoparticle platform, TERP, enables tissue-selective delivery of nucleotides and biological therapeutics to extra-hepatic sites, including brain and spleen. TERP technology is a breakthrough technology with the great potential to deliver a new era of disease-modifying genetic medicine that will make a difference to patients with a wide range of unmet medical needs.
Company Details
- Employees
- 9
- Founded
- -
- Address
- 661 Univeresity Ave., Toronto,on M5g1m1,canada
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.qurcan.com
- HQ
- Toronto, ON
Qurcan Therapeutics Inc. Questions
Qurcan Therapeutics Inc.'s website is http://www.qurcan.com
Qurcan Therapeutics Inc.'s LinkedIn profile is https://ca.linkedin.com/company/qurcan
Qurcan Therapeutics Inc. has
9 employees.
View email and phone details for 9
employees at Qurcan Therapeutics Inc..
Qurcan Therapeutics Inc.'s industry is
Pharmaceutical Manufacturing
Qurcan Therapeutics Inc.'s top competitors are
Virica Biotech,
Creatus Biosciences Inc.,
Dcx Biotherapeutics Corporation,
Noa Therapeutics,
Reverb Therapeutics,
Hdax Therapeutics,
Ripple Therapeutics,
Maman Biomedical,
Liven Proteins,
Dalriada Drug Discovery.
Qurcan Therapeutics Inc.'s categories are Pharmaceutical Manufacturing
Qurcan Therapeutics Inc.'s founding year is 2018
